RedHill Biopharma (RDHL) Other Working Capital Changes (2012 - 2023)

RedHill Biopharma (RDHL) has reported Other Working Capital Changes for 12 consecutive years, with $2.1 million the latest figure, recorded in Q2 2023.

• On a quarterly basis, Other Working Capital Changes rose 195.26% year-over-year to $2.1 million in Q2 2023; TTM through Jun 2023 was -$261000.0, a 117.37% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 218.97% from the prior year.
• Other Working Capital Changes was $2.1 million for Q2 2023 at RedHill Biopharma, up from -$783000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.4 million in Q2 2022 and troughed at -$1.4 million in Q2 2021.
• A 5-year average of $1.3 million and a median of -$243000.0 in 2018 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes surged 1121.74% in 2020 and tumbled 5323.81% in 2022, its largest moves.
• Over 5 years, Other Working Capital Changes stood at $94000.0 in 2019, then sank by 1042.55% to -$886000.0 in 2020, then jumped by 102.37% to $21000.0 in 2021, then plunged by 5323.81% to -$1.1 million in 2022, then jumped by 293.25% to $2.1 million in 2023.
• The last three Other Working Capital Changes figures came in at $2.1 million (Q2 2023), -$783000.0 (Q1 2023), and -$1.1 million (Q4 2022), per Business Quant data.